Eitan Bibi focuses on Biochemistry, Multiple drug resistance, Escherichia coli, Cell biology and Transporter. His Membrane transport protein, Mutant, Enzyme, Cell membrane and Protein structure study are his primary interests in Biochemistry. His Multiple drug resistance research is multidisciplinary, incorporating perspectives in Transport protein and Plasmid.
He combines subjects such as Proteome, Antiporter, Homeostasis, Ion transporter and Bacteria with his study of Escherichia coli. His biological study spans a wide range of topics, including Membrane, Membrane protein, Signal recognition particle receptor and Signal recognition particle. His Signal recognition particle study incorporates themes from Integral membrane protein, Biogenesis and Signal recognition particle RNA.
His main research concerns Biochemistry, Membrane protein, Escherichia coli, Cell biology and Membrane transport protein. His is involved in several facets of Biochemistry study, as is seen by his studies on Transporter, Transmembrane domain, Protein structure, Lactose permease and Permease. As a member of one scientific family, he mostly works in the field of Membrane protein, focusing on Proteases and, on occasion, Cleave and Serine protease.
His studies in Escherichia coli integrate themes in fields like Plasmid, P-glycoprotein, Multiple drug resistance, Mutant and Efflux. His Cell biology research includes themes of Biogenesis, Signal recognition particle receptor, Membrane, Translation and Signal recognition particle. His Membrane transport protein study combines topics in areas such as Membrane transport, Cell membrane, Transmembrane protein, Peptide sequence and Binding site.
His primary areas of study are Membrane protein, Cell biology, Efflux, Translation and Membrane. In his research on the topic of Membrane protein, Signal recognition particle receptor, Escherichia coli, Cold-shock domain and Plasma protein binding is strongly related with Biogenesis. His Cell biology study combines topics from a wide range of disciplines, such as Genetics, Ribosome profiling and Initiation factor.
Eitan Bibi has researched Efflux in several fields, including Multiple drug resistance, Transporter, Biophysics, Substrate and Computational biology. His research in Multiple drug resistance intersects with topics in Transport protein and Mutant. His Ribosome research is included under the broader classification of Biochemistry.
Eitan Bibi mainly investigates Efflux, Escherichia coli, Biochemistry, Membrane protein and Cell biology. His Efflux research incorporates elements of Biophysics and Transporter. His work deals with themes such as Transport protein, Multidrug transport, Computational biology and Cytoplasm, which intersect with Escherichia coli.
His Biochemistry study frequently draws connections between related disciplines such as Drug molecule. His studies deal with areas such as Transmembrane protein and Biological membrane as well as Membrane protein. The various areas that he examines in his Cell biology study include Integral membrane protein, Genetics, DNA Mutational Analysis, Ribosome profiling and Initiation factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Alkaline pH homeostasis in bacteria: new insights.
Etana Padan;Eitan Bibi;Masahiro Ito;Terry A. Krulwich.
Biochimica et Biophysica Acta (2005)
MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition
R Edgar;E Bibi.
Journal of Bacteriology (1997)
In vivo expression of the lacY gene in two segments leads to functional lac permease.
E Bibi;H R Kaback.
Proceedings of the National Academy of Sciences of the United States of America (1990)
FtsY, the prokaryotic signal recognition particle receptor homologue, is essential for biogenesis of membrane proteins.
Andrei Seluanov;Eitan Bibi.
Journal of Biological Chemistry (1997)
Structural basis for intramembrane proteolysis by rhomboid serine proteases
Adam Ben-Shem;Deborah Fass;Eitan Bibi.
Proceedings of the National Academy of Sciences of the United States of America (2007)
New prospects in studying the bacterial signal recognition particle pathway
Anat A. Herskovits;Elena S. Bochkareva;Eitan Bibi.
Molecular Microbiology (2002)
A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA.
Rotem Edgar;Eitan Bibi.
The EMBO Journal (1999)
How intramembrane proteases bury hydrolytic reactions in the membrane
Elinor Erez;Deborah Fass;Eitan Bibi.
Alkalitolerance: A biological function for a multidrug transporter in pH homeostasis
Oded Lewinson;Etana Padan;Eitan Bibi.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study.
Terry A. Krulwich;Oded Lewinson;Etana Padan;Eitan Bibi.
Nature Reviews Microbiology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: